Please login to the form below

Not currently logged in
Email:
Password:

rectal cancer

This page shows the latest rectal cancer news and features for those working in and with pharma, biotech and healthcare.

IQVIA and partners set up cancer ‘data hub’ to speed up research

IQVIA and partners set up cancer ‘data hub’ to speed up research

The announcement of the research centre comes at a time where cancer survival rates, despite increasing in rectal and colon cancer, are trailing behind other high-income countries across the world. ... The study showed that the UK performed worse than

Latest news

  • IBM teams up with Teva for global eHealth collaboration IBM teams up with Teva for global eHealth collaboration

    Willalso partner with ICON on cancer trials project.  . IBM has signed deals with Teva and ICON that will see the firms use services based on its Watson supercomputer. ... This will be applied to breast, lung, colon and rectal cancer trials and aims to

  • Valeant and Shire said to be evaluating potential Salix bids Valeant and Shire said to be evaluating potential Salix bids

    Valeant currently in final stages of Provenge acquisition.  . Valeant Pharmaceuticals is in the final stages of acquiring Dendreon's cancer vaccine Provenge but is already lining up its next acquisition prospect, ... Nevertheless, in the latter half of

  • Close but no cigar

    Despite failure to show clinical benefit, gene therapy continues to offer hope for cancer treatment. ... TNFerade has also shown potential in the treatment of rectal cancer, head and neck cancer, metastatic melanoma and oesophageal cancer.

  • Roche and Pfizer report growth

    Sales of the osteoporosis drug Bonviva, and the cancer therapy Avastin, which were up 41 per cent and 37 per cent respectively, contributed to the successful sales story to date. ... cancer). US revenue has decreased by 13 per cent. However, the

  • Contraceptive pill may protect against cancer

    In the main dataset women on the pill had statistically significant lower rates of large bowel/rectal, uterine body and ovarian cancer. ... The GP dataset also showed a reduced risk of uterine and ovarian cancer.

More from news
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Frontera Group

Welcome to Frontera Group where our agencies immerse you in the world of the patient...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics